QSAM Biosciences Valore dell'impresa
Cos'è Valore dell'impresa di QSAM Biosciences?
Valore dell'impresa di QSAM Biosciences, Inc. è $10.28M
Qual è la definizione di Valore dell'impresa?
Il valore dell'impresa è una misura del valore di mercato totale di un'azienda. È calcolato come capitalizzazione di mercato con debito, interessi di minoranza e azioni privilegiate al netto delle disponibilità liquide e mezzi equivalenti.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valore dell'impresa di aziende nel Health Care settore su OTC rispetto a QSAM Biosciences
Cosa fa QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Aziende con valore dell'impresa simili a QSAM Biosciences
- NXT Solutions ha Valore dell'impresa di $10.26M
- National Plastic Industries ha Valore dell'impresa di $10.26M
- Lake Winn Resources Corp ha Valore dell'impresa di $10.26M
- Boreal Metals ha Valore dell'impresa di $10.26M
- Dragon King ha Valore dell'impresa di $10.27M
- Therma Bright ha Valore dell'impresa di $10.28M
- QSAM Biosciences ha Valore dell'impresa di $10.28M
- Grid Metals ha Valore dell'impresa di $10.28M
- Fox Marble PLC ha Valore dell'impresa di $10.29M
- Coral India Finance and Housing ha Valore dell'impresa di $10.30M
- Trejhara Solutions ha Valore dell'impresa di $10.31M
- Sprout Tiny Homes ha Valore dell'impresa di $10.31M
- Oculus VisionTech ha Valore dell'impresa di $10.32M